S44 - MS Risk Factors and Modifications

Event Time: Thursday April 27, 2017 3:30 pm to 5:30 pm
Topic(s): MS and CNS Inflammatory Disease
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
3:30 PM 001 The effect of hospitalization on subsequent disability in multiple sclerosis Ruth-Ann Marrie, MD
Dr. Marrie has nothing to disclose.

3:42 PM 002 A survey of current dietary habits within a large population of people with multiple sclerosis Kathryn C. Fitzgerald
Dr. Fitzgerald has nothing to disclose.

3:54 PM 003 Environmental risk factors associated with pediatric MS: The role of remote viral infections and vitamin D revisited. Shayandokht Taleb, MD
Dr. Taleb has nothing to disclose.

4:06 PM 004 Cholecalciferol supplementation in Relapsing Multiple Sclerosis patients treated with subcutaneous interferon beta-1a: a Randomized Controlled Trial. William Camu, MD
Dr. Camu has received personal compensation for activities with Actelion, Biogen-Idec, Merck Serono, Novartis and Sanofi in the form of honoraria or research grants.

4:18 PM 005 High dose cholecalciferol (vitamin D3) oil as add-on therapy in subjects with relapsing-remitting multiple sclerosis (RRMS) receiving subcutaneous interferon 1a (scIFN?-1a) Raymond Hupperts
Dr. Smolders has nothing to disclose.

4:30 PM 006 Maternal levels of Epstein-Barr virus IgG antibodies and risk of multiple sclerosis in offspring in the Finnish Maternity Cohort Kassandra Munger
Dr. Munger has nothing to disclose.

4:42 PM 007 Epstein-Barr virus, Cytomegalovirus, the Hygeine Hypothesis and Multiple Sclerosis Susceptibility: A Multi-Ethnic Study Annette Langer-Gould, MD, PhD
Dr. Langer-Gould has nothing to disclose.

4:54 PM 008 Familial Transverse Myelitis Associated with Mutation in VPS37A Gene Santiago Pardo
Dr. Pardo has nothing to disclose.

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses